GeDiPNet Resources
Explore GeDiPNet's data sources, tools, and integration partners.
Explore
What are you looking for?
Jump directly to the Help manual, dataset Versions, Community & data sources, FAQ, API documentation, or the Glossary.
Guide
Help
Step-by-step user manual: search, browse genes & diseases, pathway analysis, enrichment, comorbidity, and more.
Explore
Data
Versions
Compare the live Version 2 dataset against the frozen Version 1 snapshot — what's in each, and when to use which.
Explore
Community
Community
Partner databases, cross-referenced resources, and data sources integrated into GeDiPNet.
Explore
Support
FAQ
Answers to common questions about data curation, sources, scoring, and platform usage.
Explore
Developer
API
Technical guide to integrating GeDiPNet gene-disease data into your own research pipelines.
Explore
Reference
Glossary
Plain-language definitions for every analysis term GeDiPNet uses — p-value, weighted degree, comorbidity score, and more.
Explore
Jump To
Quick Links
Popular pages and how-to guides, one click away.
Introduction to GeDiPNet
How to search genes & diseases
Browse genes A–Z
Browse diseases
Enrichment analysis
Comorbidity analysis
Polypharmacological targets
Venn analysis
Glossary of terms
Dataset versions (v1 vs v2)
Cite GeDiPNet in your paper
Partner databases
Frequently Asked Questions
Contact & support
Cross-Referenced Resources
Data Sources
GeDiPNet integrates data from 11 authoritative bioinformatics resource categories. Click any category to expand.
11 categories
38 sources
Integrates nomenclature, RefSeqs, maps, pathways, variations, and phenotypes across species.
Expression profiles of human genes at the mRNA and protein level across tissues.
Comprehensive catalog of Mendelian traits, disorders, human genes, and genetic phenotypes.
HUGO Gene Nomenclature Committee — standardized names and symbols for all human genes.
Genome browser for vertebrate genomes supporting comparative genomics and transcriptional regulation.
Comprehensive platform for human gene-disease and variant-disease associations.
Public archive of human genetic variations and associated phenotypes with supporting evidence.
Standardized vocabulary of phenotypic abnormalities encountered in human disease.
Authoritative compendium of human genes and genetic phenotypes.
Global knowledge base for rare diseases and orphan drugs with expert-validated information.
NIH-funded resource defining clinical relevance of genes and variants for precision medicine.
EMBL-EBI's catalog of published genome-wide association studies, linking SNPs to disease and trait associations.
Gene Curation Coalition — harmonized gene-disease validity classifications from multiple clinical curation groups.
Knowledge platform for exploratory analysis of psychiatric diseases and their associated genes.
Repository of human single nucleotide variations, microsatellites, and small-scale insertions/deletions.
Structured, controlled vocabularies for annotating genes and gene products in molecular and cellular biology.
Comprehensive, experimentally validated database of microRNA-target interactions.
Manually curated database of human and mouse transcriptional regulatory networks.
U.S. National Library of Medicine registry of clinical trials worldwide — checks whether a predicted drug is already approved, in trial, or untested for a given disease.
Genotype-Tissue Expression project — reference gene expression levels across human tissues, used to verify a predicted target gene is actually expressed where it matters.
EMBL-EBI's gene expression database across conditions and diseases — surfaces relevant transcriptomic studies for a disease.
Cancer genomics portal providing TCGA (The Cancer Genome Atlas) expression data, used for cancer-specific transcriptomic cross-referencing.
Side Effect Resource — known, on-label side effects listed on official drug labels.
Statistically significant off-label side effect signals mined from FDA adverse event reports, not listed on the official drug label.
Predicts Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties, including blood-brain barrier penetration and drug-likeness, from a drug's chemical structure.
EMBL-EBI's manually curated database of bioactive drug-like molecules, used to resolve a drug's chemical structure (SMILES).
NIH's open chemistry database, used as a fallback to resolve a drug's chemical structure by name when ChEMBL doesn't have it.
NCI's name-to-structure lookup service, used as a final fallback to resolve a drug's chemical structure when neither ChEMBL nor PubChem recognizes the name.
No data sources match your search.